Clinical Trials Sponsored by Hellenic Society of Surgical Oncology

Total 247 results

Hellenic Society of Surgical Oncology

Unknown

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Cancer | Thromboembolism | Cancer Diagnosis

Greece
Hellenic Cooperative Oncology Group
Hellenic Society of Medical Oncology

Active, not recruiting

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
Hellenic Society of Medical Oncology

Completed

Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma
Hellenic Society of Medical Oncology

Recruiting

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

Greece
Hellenic Society of Medical Oncology

Unknown

Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients

Deep Vein Thrombosis | Pulmonary Embolism | Vena Cava Thrombosis | Iliac; Thrombosis

Greece
Hellenic Society of Medical Oncology

Completed

Study on Management Thrombosis in Greek Cancer Patients (GMaT)

Thrombosis

Greece
Austrian Society Of Surgical Oncology

Completed

Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility (DYSMOSTIM)

Quality of Life | Gastro Esophageal Reflux | Dysphagia | Electrical Stimulation of the Lower Esophageal Sphincter

Austria
Austrian Society Of Surgical Oncology

Completed

Morbidity in Open Versus Minimally Invasive Esophagectomy (MIOMIE)

Esophageal Cancer
Austrian Society Of Surgical Oncology

Completed

Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer (ASSO-LM1)

Metastatic Colorectal Cancer

Austria
Hellenic Society of Interventional Cardiology

Completed

Ticagrelor in Remote Ischemic Preconditioning Study (TRIP)

Periprocedural Myocardial Infarction

Greece
Hellenic Society of Hematology
GlaxoSmithKline

Recruiting

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

Neoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease

Greece
Hellenic Society of Hematology
GlaxoSmithKline

Active, not recruiting

Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma (BelaRd)

Multiple Myeloma

Greece
Matthias Paireder
Medtronic - MITG

Unknown

Radiofrequency Ablation in Patients With Barrett's Esophagus (RABE)

Gastroesophageal Reflux Disease | Barrett's Esophagus | Radiofrequency Ablation

Austria
Hellenic Society of Hematology
GlaxoSmithKline

Not yet recruiting

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Neoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
Hellenic Society of Hematology
GlaxoSmithKline

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Neoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma Cell

Greece
Hellenic Society of Hematology
Sanofi

Not yet recruiting

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Neoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Renal Impairment

Greece
Hellenic Society of Hematology
Sanofi

Not yet recruiting

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Neoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Renal Impairment

Greece
Maria Sklodowska-Curie National Research Institute...
Polish Society of Surgical Oncology

Recruiting

Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer

Rectal Cancer | Rectal Neoplasms

Poland
University of Patras
Hellenic Cardiology Society

Completed

The GReek AntiPlatElet (GRAPE) Registry: A Multicenter Observational Prospective Investigation of Antiplatelet Treatment in Patients With Acute Coronary Syndrome Subjected to Percutaneous Coronary Intervention (GRAPE)

Acute Coronary Syndrome

Greece
Daniela Kandioler
Medical University of Vienna; Austrian Society Of Surgical Oncology

Completed

p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer (PANCHO)

Esophageal Cancer

Austria
Hellenic Society of Hematology
Janssen Pharmaceuticals

Completed

Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment (DARE)

Relapsed/Refractory Multiple Myeloma

Greece
Hellenic Society of Hematology
Janssen Pharmaceuticals

Unknown

Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma (REBUILD)

Multiple Myeloma

Greece
Fondazione Policlinico Universitario Agostino Gemelli...
European Society of Surgical Oncology

Unknown

Complete Pathologic Response Rectal Cancers (CORSiCA)

Rectal Cancer

Italy
Aristotle University Of Thessaloniki
Hellenic Society of Hypertension

Completed

The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure

Hypertension | Diabetes | Insulin Resistance

Greece
University of Athens
Hellenic Cooperative Oncology Group

Completed

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Amyloidosis

Greece
Hellenic Cooperative Oncology Group
University of Ioannina

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Greece
Society of Interventional Oncology

Recruiting

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) (ACCLAIM)

Colorectal Liver Metastases

United States, Netherlands, Greece
European Organisation for Research and Treatment...
European Society of Surgical Oncology

Completed

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program (CLIMB)

Colorectal Carcinoma | Liver Metastasis

France, Sweden, Italy, Denmark, Germany, Spain, Netherlands, Serbia, Austria, Switzerland, Belgium, United Kingdom
Hellenic Society for the Study of Bone Metabolism

Completed

Denosumab for the Treatment of Adult LCH

Langerhans Cell Histiocytosis

Greece
Alexandra Hospital, Athens, Greece
Hellenic Society of Gastroenterology

Completed

Concomitant Versus Hybrid Regimen for H. Pylori Eradication

H.Pylori Infection | H.Pylori Gastrointestinal Disease | H. Pylori Associated Phlegmonous Gastritis

Greece
Hellenic Society of Hematology
Takeda; Janssen Pharmaceutica NV

Unknown

Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (DARIA)

Multiple Myeloma

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Unknown

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

CRC

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Gastric Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer

Pancreatic Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer

Colorectal Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC

Colorectal Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Breast Cancer

Greece
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); American Society of Clinical Oncology; Society...

Completed

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Melanoma (Skin)

United States
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Ovarian Cancer

Greece

Clinical Trials Sponsored by Hellenic Society of Surgical Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations